- World rank, all time
- #8,490 of 42,892
- Rank in United States
- #1,903 of 8,685
- Research works
- 217 ▲ 18% vs 2013–17
- Citations
- 12k 53.8 per fractional work
- Top-10% rate
- 11.3% record average 16.5%
- Open access
- 34% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.1×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 7.1×
- Immunology and Microbiology 6.6×
- Medicine 2.3×
- Health Professions 1.9×
- Dentistry 0.6×
- Economics, Econometrics and Finance 0.4×
- Chemistry 0.2×
- Computer Science 0.2×
- Arts and Humanities 0.1×
- Materials Science 0.1×
- Physics and Astronomy 0.1×
- Engineering 0.1×
- Neuroscience 0.1×
- Social Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Mathematics 0.1×
Which keywords describe research at Repligen (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Lymphoma, Rituximab, Gene Expression, Gene Expression Profiling, Molecular Profiling, PET Imaging, Targeted Therapy and Genomic Instability.
- Soft Tissue Sarcoma
- Innate Immunity
- Fc Receptors
- Recombinant Proteins
- Leukemia
- Biopharmaceuticals
- Mammalian Cells
- Clinical Practice Guidelines
- Tumor Microenvironment
- Real-Time PCR
- Normalization
- Monoclonal Antibodies
- Chemotherapy
- Mutational Signatures
- Genetic Pathogenesis
- Cancer Genomics
- Genomic Instability
- PET Imaging
- Gene Expression Profiling
- Rituximab
- Lymphoma
- Gene Expression
- Molecular Profiling
- Targeted Therapy
- Prognostic Factors
- Classification
- Immunotherapy
- Glycosylation
- Data Analysis
- Therapeutic Antibodies
- Quantitative
- Cancer
- Cancer Immunotherapy
- Monoclonal Antibody
- Recombinant Protein
- Immunogenicity
- Protein Aggregation
- Antibody Engineering
- Genetic Mutations
- Osteosarcoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Lymphoma5▲ 74×3 topics
- Rituximab4▲ 75×2 topics
- Gene Expression4▲ 17×7 topics
- Gene Expression Profiling4▲ 109×2 topics
- Molecular Profiling4▲ 90×2 topics
- PET Imaging4▲ 51×3 topics
- Targeted Therapy4▲ 39×3 topics
- Genomic Instability3▲ 76×2 topics
- Prognostic Factors3▲ 19×5 topics
- Cancer Genomics3▲ 115×1 topic
- Classification3▲ 18×1 topic
- Genetic Pathogenesis3▲ 154×1 topic
- Immunotherapy3▲ 12×7 topics
- Mutational Signatures3▲ 115×1 topic
- Glycosylation3▲ 67×2 topics
- Chemotherapy3▲ 10×8 topics
- Data Analysis3▲ 27×4 topics
- Monoclonal Antibodies3▲ 80×3 topics
- Therapeutic Antibodies3▲ 103×2 topics
- Normalization3▲ 135×2 topics
- Quantitative2▲ 58×1 topic
- Real-Time PCR2▲ 195×1 topic
- Cancer2▲ 3.7×9 topics
- Tumor Microenvironment2▲ 10×4 topics
- Cancer Immunotherapy2▲ 27×3 topics
- Clinical Practice Guidelines2▲ 7.6×3 topics
- Monoclonal Antibody2▲ 82×2 topics
- Mammalian Cells2▲ 168×1 topic
- Recombinant Protein2▲ 168×1 topic
- Biopharmaceuticals2▲ 74×2 topics
- Immunogenicity2▲ 89×2 topics
- Leukemia2▲ 43×2 topics
- Protein Aggregation2▲ 71×1 topic
- Recombinant Proteins2▲ 119×1 topic
- Antibody Engineering1▲ 62×1 topic
- Fc Receptors1▲ 62×1 topic
- Genetic Mutations1▲ 7.8×3 topics
- Innate Immunity1▲ 11×3 topics
- Osteosarcoma1▲ 69×1 topic
- Soft Tissue Sarcoma1▲ 61×1 topic
Which research topics does Repligen (United States) publish most on?
By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Molecular Biology Techniques and Applications and Viral Infectious Diseases and Gene Expression in Insects.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
- 2 Cancer Genomics and Diagnostics Cancer Research 3 works
- 3 Molecular Biology Techniques and Applications Molecular Biology 2 works
- 4 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
- 5 Protein purification and stability Molecular Biology 2 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 7 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 8 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 9 CAR-T cell therapy research Oncology 1 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Repligen (United States)'s research output changed?
Output in 2018–2022 was 18% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Waltham
- Brandeis University
- Bentley University
- PerkinElmer (United States)
- Thermo Fisher Scientific (United States)
- Education Development Center
- Foster-Miller (United States)
- Boston Engineering (United States)
- Fresenius Medical Care (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.